Skip to main content
Have a personal or library account? Click to login
Distribution of the Most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia Cover

Distribution of the Most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia

Balkan Journal of Medical Genetics
Volume 17 (2014): Issue 2 (December 2014)
By: ,  ,  ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Apr 2015
References

References

  1. 1. Ma Q, Lu AY. Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev. 2011; 63(2): 437-459.
    Open DOISearch in Google Scholar
  2. 2. Foster MW, Sharp RR. Race, ethnicity, and genomics: Social classifications as proxies of biological heterogeneity. Genome Res. 2002; 12(6): 844-850.
    Open DOISearch in Google Scholar
  3. 3. Stranger BE, Stahl EA, Raj T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics. 2011; 187(2): 367-383.
    Open DOISearch in Google Scholar
  4. 4. Li J, Zhang L, Zhou H, Stoneking M, Tang K. Global patterns of genetic diversity and signals of natural selection for human ADME genes. Hum Mol Genet. 2011; 20(3): 528-540.
    Open DOISearch in Google Scholar
  5. 5. Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scale. Pharmacogenet Genomics. 2009; 19(2): 170-179.
    Open DOISearch in Google Scholar
  6. 6. Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, et al. Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res. 2010; 20(8): 1020-1036.
    Open DOISearch in Google Scholar
  7. 7. McGraw J, Waller D. Cytochrome P450 variations in different ethnic populations. Expert Opin Drug Metab Toxicol. 2012; 8(3): 371-382.
    Open DOISearch in Google Scholar
  8. 8. Sim SC, Kacevska M, Ingelman-Sundberg M. Pharmacogenomics of drug-metabolizing enzymes: A recent update on clinical implications and endogenous effects. Pharmacogenomics J. 2013; 13(1): 1-11.
    Open DOISearch in Google Scholar
  9. 9. Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009; 41(2): 89-295.
    Open DOISearch in Google Scholar
  10. 10. Rebsamen MC, Desmeules J, Daali Y, Chiappe A, Diemand A, Rey C, et al. The AmpliChip CYP450 test: Cytochrome P450 2D6 genotype assessment and phenotype prediction. Pharmacogenomics J. 2009; 9(1): 34-41.
    Open DOISearch in Google Scholar
  11. 11. Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics. 2007; 17(2): 93-101.
    Open DOISearch in Google Scholar
  12. 12. Kalow W. Pharmacogenetics: A historical perspective. In: McLeod HL, DeVane CL, Haga SB, Johnson JA, Knoel DL, Kolesar JM, et al., Eds. Pharmacogenomics: Application to Patient Care, 2nd ed. Lenexa, KS: American College of Clinical Pharmacy. 2009: 22-31.
    Search in Google Scholar
  13. 13. van Schaik RH, van der Heiden IP, van den Anker JN, Lindemans J. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem. 2002; 48(10): 1668-1671.
    Open DOISearch in Google Scholar
  14. 14. Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, et al. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Clin Pharmacol Ther. 1999; 66(2): 185-192.
    Open DOISearch in Google Scholar
  15. 15. Buzková H, Pechandová K, Slanar O, Perlik F. Frequency of single nucleotide polymorphisms of CYP-2D6 in the Czech population. Cell Biochem Funct. 2008; 26(1): 76-81.
    Open DOISearch in Google Scholar
  16. 16. Qumsieh RY, Ali BR, Abdulrazzaq YM, Osman O, Akawi NA, Bastaki SM. Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis. PLoS One. 2011; 6(12): e28943. doi: 10.1371/journal.pone.0028943.
    Open DOISearch in Google Scholar
  17. 17. Scordo MG, Caputi AP, D’Arrigo C, Fava G, Spina E. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol Res. 2004; 50(2): 195-200.
    Open DOISearch in Google Scholar
  18. 18. Bozina N, Granić P, Lalić Z, Tramisak I, Lovrić M, Stavljenić-Rukavina A. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Croat Med J. 2003; 44(4): 425-428.
    Search in Google Scholar
  19. 19. Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, et al. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam Clin Pharmacol. 2007; 21(4): 419-426.
    Open DOISearch in Google Scholar
  20. 20. Gaikovitch EA, Cascorbi I, Mrozikiewicz PM, Brockmöller J, Frötschl R, et al. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of Pglycoprotein in a Russian population. Eur J Clin Pharmacol. 2003; 59(4): 303-312.
    Open DOISearch in Google Scholar
  21. 21. Yamada H, Dahl ML, Lannfelt L, Viitanen M, Winblad B, Sjoqvist F. CYP2D6 and CYP2C19 genotypes in an elderly Swedish population. Eur J Clin Pharmacol. 1998; 54(6): 479-481.
    Open DOISearch in Google Scholar
  22. 22. Falzoi M, Pira L, Lazzari P, Pani L. Analysis of CYP2D6 allele frequencies and identification of novel SNPs and sequence variations in Sardinians. ISRN Genet. 2013; 2013. Article ID 204560; http://dx.doi.org/10.5402/ 2013/204560.
    Open DOISearch in Google Scholar
  23. 23. Jakovski K, Kapedanovska Nestorovska A, Labacevski N, Dimovski AJ. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population of R. Macedonia. Pharmazie. 2013; 68(11): 893-898.
    Search in Google Scholar
  24. 24. Kapedanovska Nestorovska A, Cvetkovska Dimitrovska A, Suturkova Lj. Genetic profile of CYP2C19 polymorphisms in population from Republic of Macedonia. Macedonian Pharmaceutic Bull. 2011; 57(Suppl): 346-348.
    Search in Google Scholar
  25. 25. Jakovski K, Kapedanovska Netorovska A, Labacevski N, Dimovski AJ. Frequency of most common CYP3A5 polymorphisms in the healthy population of the Republic of Macedonia. Macedonian Pharmaceutic Bull. 2012; 58(1-2): 25-31.
    Open DOISearch in Google Scholar
  26. 26. Hildebrandt MA, Carrington DP, Thomae BA, Eckloff BW, Schaid DJ, Yee VC, et al. Genetic diversity and function in the human cytosolic sulfotransferases. Pharmacogenomics J. 2007; 7(2): 133-143.
    Open DOISearch in Google Scholar
  27. 27. Horsfall LJ, Zeitlyn D, Tarekegn A, Bekele E, Thomas MG, Bradman N, et al. Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations. Ann Hum Genet. 2011; 75(2): 236-246.
    Open DOISearch in Google Scholar
  28. 28. Polimanti R, Carboni C, Baesso I, Piacentini S, Iorio A, De Stefano GF, et al. Genetic variability of glutathione S-transferase enzymes in human populations: Functional inter-ethnic differences in detoxification systems. Gene. 2013; 512(1): 102-107.
    Open DOISearch in Google Scholar
  29. 29. Sterjev Z, Josifovski T, Panovski M, Sututkova L, Dimovski AJ. The SULT1A1 allele with low potential for estrogen inactivation is associated with reduced colorectal cancer risk in postmenopausal women. Balkan J Med Genet. 2005; 8(3-4): 43-48.
    Search in Google Scholar
  30. 30. Bajro MH, Josifovski T, Panovski M, Jankulovski N, Nestorovska AK, Matevska N, et al. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer. Cancer Genet. 2012; 205(4): 163-167.
    Open DOISearch in Google Scholar
  31. 31. Sharma R, Hoskins JM, Rivory LP, Zucknick M, London R, Liddle C, et al. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients. Clin Cancer Res. 2008; 14(3): 817-825.
    Open DOISearch in Google Scholar
  32. 32. Wang H, Wang J, Zhao L, Liu X, Mi W. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet. 2012; 4: 13-77.
    Open DOISearch in Google Scholar
  33. 33. Acuña M, Eaton L, Cifuentes L, Massardo D. Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population. Br J Clin Pharmacol. 2006; 61(6): 778-782.
    Open DOISearch in Google Scholar
  34. 34. Alzahrani AM, Ragia G, Hanieh H, Manolopoulos VG. Genotyping of CYP2C9 and VKORC1 in the Arabic Population of Al-Ahsa, Saudi Arabia. Biomed Res Int. 2013; 2013: 315980. doi: 10.1155/2013/3159980.
    Search in Google Scholar
  35. 35. Matevska N, Josifovski T, Kapedanovska A, Sterjev Z, Serafimoska Z, Panovski M, et al. Methylenetetrahydrofolate reductase C677T polymorphism and risk of colorectal cancer in the Macedonian population. Balkan J Med Genet. 2008; 11(2):17-24.
    Open DOISearch in Google Scholar
  36. 36. Kapedanovska Nestorovska A, Sterjev Z, Serafimoska Z, Josifovski T, Petrusevska N, Suturkova L, et al. Thymidylate synthase enhancer region (TSER) 2R/3R polymorphisms as an independent risk factor for colorectal cancer in Macedonian population. Macedonian Pharmaceutic Bull. 2011; 57(Suppl): 348-349.
    Search in Google Scholar
DOI: https://doi.org/10.2478/bjmg-2014-0069 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 5 - 14
Published on: Apr 10, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Drug metabolizing enzymes (DMEs),
Drug target,
Allelic variants,
Republic of Macedonia
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2015 Kapedanovska A. Nestorovska, K. Jakovski, Z. Naumovska, Hiljadnikova M. Bajro, Z. Sterjev, A. Eftimov, Matevska N. Geskovska, L. Suturkova, K. Dimitrovski, N. Labacevski, A. J. Dimovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 17 (2014): Issue 2 (December 2014)
Next article